Introduction
============

Acute lower respiratory infection (ALRI) is a major cause of morbidity and mortality worldwide in children younger than 5 years. [@JR1800105-1] Respiratory syncytial virus (RSV) is the most common viral pathogen causing acute respiratory infection (ARI) in young children globally and is an important cause of ARI-related hospitalization and death, especially in developing countries. [@JR1800105-2] [@JR1800105-3] It was estimated globally in 2015, that 33.1 million cases of RSV-ALRI resulted in approximately 3.2 million hospital admissions and 59,600 in-hospital deaths in children younger than 5 years. [@JR1800105-4] There are other viruses associated with ALRI in children younger than 5 years including human metapneumovirus (HMPV), rhinovirus, adenovirus, bocavirus, coronavirus, parainfluenza virus, and influenza virus. [@JR1800105-5] [@JR1800105-6] All these viruses, except for influenza virus, are more likely to occur in children younger than 5years in the Eastern Mediterranean region than in older children and adults. [@JR1800105-7]

Data about the incidence and frequency of common viruses causing ARI/ALRI in young children and the risk factors for the severe presentation of ARI/ALRI in developing countries, particularly in the Middle East, are scarce. [@BR1800105-8] [@JR1800105-9] [@JR1800105-10] Therefore, there are limitations affecting the estimation of the burden of ARI/ALRI due to viruses on health resources and the implementation of strategies for prevention such as RSV prophylaxis [@JR1800105-11] and a future RSV vaccine. [@JR1800105-12]

Methods of detecting RSV and other viruses causing ARI/ALRI include antigen detection, cell culture, serology testing, and reverse transcriptase-polymerase chain reaction (RT-PCR), with the latter having the highest detection sensitivity among other testing modalities. [@JR1800105-13] The use of RT-PCR to detect the viral pathogens causing ARI in young children has been limited in Jordan due to its high cost. Few studies have been conducted in Jordan to detect the etiology of ARI using RT-PCR for diagnostic testing. Most of the available studies tested children for only one virus. [@JR1800105-14] [@JR1800105-15] [@JR1800105-16] [@JR1800105-17]

Halasa et al studied the viral etiology of ARI/ALRI in hospitalized children younger than 2 years in Amman, the capital city of Jordan, and RSV was the most commonly detected virus. [@JR1800105-18] The peak months of RSV infection were reported to be mainly January and February. [@JR1800105-18] However, RSV prophylaxis is not the standard of care for high-risk groups of children who are vulnerable for RSV infection in Jordan; it is not available in government or public hospitals nor it is covered by insurance. Therefore, further studies in Jordan are warranted to highlight the burden of viral ARI/ALRI caused by RSV to convince policy makers of the necessity of prevention. In addition, identifying the etiology and the frequency of other viruses causing ARI/ALRI can guide practitioners in optimizing the management of patients with ARI/ALRI, such as avoiding the overuse of antibiotics, especially given that viral testing is not a routine practice in diagnosing children admitted to the hospitals with ARI/ALRI in Jordan. Identifying the risk factors for hospital admission and severe disease in young children with ARI/ALRI is vital to accurately estimating the morbidity and mortality associated with ARI/ALRI and thus the burden imposed on individuals and health system in Jordan.

The objectives of this study were to identify the viruses causing ARI/ALRI using real-time RT-PCR in children younger than 5 years who were hospitalized during winter season of 2016 in two main hospitals in Irbid, Northern Jordan, which is in a different geographic area and has different population characteristics from Amman and to determine demographic and clinical characteristics of patients admitted with ARI/ALRI and the risk factors for increased length of hospital stay (LoS) and severe disease.

Methods
=======

Study Design and Setting
------------------------

This was a prospective viral surveillance study of children younger than 5 years diagnosed with ARI who were admitted to Princess Rahmah Hospital (PRH, the main community children\'s hospital in Northern Jordan that is run by the Ministry of Health) and King Abdullah University Hospital (KAUH, the only university-based hospital and tertiary referral health center in Irbid, Northern Jordan). The study was conducted over a 3-month period from January 15 to April 15, 2016. Children were enrolled 7 days a week within 48 hours of admission. The purpose and methodology of the study were discussed with parents, and informed consent was obtained prior to enrollment. All children younger than 5 who were hospitalized with fever (\>100.4°F/38.0°C) and respiratory symptoms or respiratory symptoms alone in both hospitals and diagnosed with ARI were included. These patients were classified as having ALRI if they presented with cough or difficulty breathing in addition to tachypnea or any other symptom or sign indicative of lower respiratory tract infection, including retractions, flaring, grunting, wheezing, and crackles. Severe ALRI was defined as the presence of cough or difficulty breathing in addition to one or more of the following: retractions, nasal flaring, grunting, oxygen saturation (SpO ~2~ ) \< 90% at room air, altered mental status, intensive care unit (ICU) admission, or patient death. [@OR1800105-19]

Viral Detection
---------------

Nasopharyngeal sampling was performed with diagnostic swabs and transport medium (Puritan UniTranz-RT Transport System with PurFlock Ultra swab \[25--3317-U\]; UT-317). Samples were stored at −80°C until they were tested with real-time RT-PCR for viruses using a multiplex identification kit (AmpliSens ARVI-screen-FRT PCR kit). [@OR1800105-20] The viruses identified were RSV, HMPV, human rhinovirus (HRV), human adenovirus (HAdV), human bocavirus (HBoV), α corona viruses 229E and NL63 (HCoV1), β corona viruses OC43 and HKU1 (HCoV2), and human parainfluenza viruses (HPIV) 1--4.

Demographic and Clinical Data Collection
----------------------------------------

Data were collected from parents through face-to-face interviews. Questionnaires were also completed to collect data on patient age, gender, gestational age, birth weight, chronic lung disease of prematurity, breast feeding history, daycare attendance, the presence of siblings older and younger than 5 years, smoking exposure, antibiotic use prior to hospitalization, and the presence of a chronic illness, such as congenital heart disease, neuromuscular, neurological, cerebral palsy, seizure disorder, developmental delay, growth retardation, down syndrome, anatomical lung problem, cystic fibrosis (CF), asthma, hematological disease, renal, and metabolic diseases. Prematurity was defined as gestational age \< 37 weeks, [@OR1800105-21] and low birth weight was defined as birth weight \< 2.5 kg. [@OR1800105-22] The symptoms and physical examination findings at the time of presentation, including SpO ~2~ readings, were recorded. Axillary temperature was measured in all patients. Tachypnea was defined as a respiratory rate ≥ 60/minute for infants younger than 2 months, ≥ 50/minute for infants 2 to 12 months old, and ≥ 40/minute for children 12 to 60 months old. [@OR1800105-19] Medical charts were reviewed to retrieve the LoS, medications used, leukocyte counts, final diagnoses, and survival outcomes. The chest radiograph of each patient was read by a pediatric radiologist who was blinded to the clinical data and viral testing results.

Statistical Analysis
--------------------

Data are described using means and standard deviation (SD) for continuous variables and frequencies and percentages for categorical variables. The frequency of RSV and other viruses causing ARI/ALRI in children younger than 5 years are presented as frequency distributions. The relevant demographic and clinical characteristics of RSV-positive patients were compared with those of RSV-negative patients using the chi-square test. Multivariate analysis of factors associated with LoS in the whole cohort was conducted using the general linear model procedure. Risk factors for severe disease presentation and mortality were analyzed with binary logistic regression analysis. The variables were included in the model stepwise and those with *p * \< 0.10 in the univariate analysis were included in the multivariate model of risk factors. Possible associated factors were examined for evidence of multicollinearity, which was reflected by either the changes in the direction of effect between the univariate and multivariate analysis, or implausible standard errors for a particular variable. A *p* -value of \< 0.05 was considered statistically significant. Analysis was performed using IBM SPSS 20 (SPSS Inc., Chicago, IL).

Results
=======

Study Population
----------------

There were 485 patients initially recruited into this study, 6 were excluded after a final diagnosis of meningitis ( *n*  = 2), urinary tract infection ( *n*  = 2), or gastroenteritis ( *n*  = 2). In total, 479 patients were diagnosed with ARI (302 males \[63%\] and 177 females \[37%\]). Their ages ranged between 1 and 60 months, with a mean (SD) age of 10.4 (11.6) months. The majority (89.8%) was aged ≤ 24 months, 72.7% were aged ≤ 12 months, and approximately one-half (52.6%) were aged ≤ 6 months. Of all patients, 15.0% were premature (specifically 29--36 weeks), 20.5% had a history of low birth weight, and 4.4% had chronic lung disease. Among all the patients, only 29.6% were exclusively breastfed, 7.3% attended daycare, 81.6% had at least one sibling, 75.6% were exposed to smoke at home, 50.5% got antibiotics prior to hospitalization, and 84.6% received antibiotics during hospitalization. A chronic illness presented in 15.9% of patients. The diagnosis upon admission was bronchiolitis in 49.7%, bronchopneumonia in 23.0%, and pneumonia in 15.2% of the children. The remaining children had other diagnoses, including asthma exacerbation, rule out sepsis, croup, pertussis-like illness, CF exacerbation, and fever for investigation. The mean (SD) LoS was 3.56 (2.4) days. Three patients died; one was positive for HMPV, and the other two were not positive for any of the tested viruses (bacterial cultures were negative in all patients who died).

Viral Detection
---------------

A virus was detected in 53.9% of the children. RSV was the most commonly detected virus (34.0%), followed by HRV (15.7%), HMPV (6.9%), and HAdV (4.2%). Less common viruses were HBoV (2.5%), HCoV2 (1.5%), HPIV1 (1.5%), HPIV2,3,4 (0.6%), and HCoV1 (0.4%) ( [Fig. 1](#FI1800105-1){ref-type="fig"} ). Of the 163 RSV-positive children, 27.6% were positive for one or two other viruses.

![Frequency of viruses detected in hospitalized patients with acute respiratory infection (ARI).](10-1055-s-0039-1692972-i1800105-1){#FI1800105-1}

Characteristics of RSV-Positive ARI Patients Compared with Those of RSV-Negative ARI Patients
---------------------------------------------------------------------------------------------

[Table 1](#TB1800105-1){ref-type="table"} shows the relevant demographic and clinical characteristics of RSV-positive patients compared with RSV-negative patients. In comparison to RSV-negative patients, RSV-positive children were significantly younger ( *p*  = 0.030) and more likely to have chronic lung disease (7.4 vs. 2.8%; *p*  = 0.022). Compared with RSV-negative children, RSV-positive children were more likely to present with cough (97.5 vs. 92.1%, *p*  = 0.018), rhinorrhea (63.8 vs. 51.9%; *p*  = 0.013), difficulty breathing (93.3 vs. 83.5%; *p*  = 0.003), retraction (28.8% vs. 20.6%; *p*  = 0.043), flaring (14.1 vs. 7.0%; *p*  = 0.011), grunting (7.4 vs. 2.5%; *p*  = 0.004), and wheezing on auscultation (39.9 vs. 26.9%; *p*  = 0.004). The mean respiratory rate was significantly higher in RSV-positive patients than in RSV-negative (55.0 vs. 51.4; *p*  = 0.001). Interstitial markings on X-rays were more pronounced in RSV-positive patients than in RSV-negative patients (40.3 vs. 31.0%; *p*  = 0.047). The two study groups were not significantly different in terms of ICU admission, death, and severe ALRI.

###### The relevant demographic and clinical characteristics of RSV-positive patients compared with RSV-negative patients

  Variable                               RSV-negative patients   RSV-positive patients   *p* -Value [a](#FN1800105-3){ref-type="table-fn"}          
  -------------------------------------- ----------------------- ----------------------- --------------------------------------------------- ------ -----------
  Age (mo)                                                                                                                                          **0.03**
    ≤  6                                 161                     50.9                    91                                                  55.8   
   6.1--12                               56                      17.7                    40                                                  24.5   
   12.1--24                              61                      19.3                    21                                                  12.9   
   \> 24                                 38                      12.0                    11                                                  6.7    
  Gender                                                                                                                                            0.341
   Male                                  204                     64.6                    98                                                  60.1   
   Female                                112                     35.4                    65                                                  39.9   
  Premature                              46                      14.6                    26                                                  16.0   0.686
  Low birth weight                       69                      22.3                    29                                                  18.0   0.274
  Chronic lung disease                   9                       2.8                     12                                                  7.4    **0.022**
  Breastfeeding                          225                     71.2                    124                                                 76.1   0.304
  Daycare                                21                      6.6                     14                                                  8.6    0.439
  Siblings below 5 years old             186                     58.9                    88                                                  54.0   0.307
  Siblings 5 years or older              161                     50.9                    84                                                  51.5   0.904
  Smoking exposure                       246                     77.8                    116                                                 71.2   0.107
  Having chronic disease                 50                      15.8                    26                                                  16.0   0.971
  Family history of atopy                99                      31.3                    58                                                  35.6   0.347
  Antibiotics prior to hospitalization   165                     52.4                    77                                                  47.5   0.316
  Presenting symptoms                                                                                                                               
   Fever \> 38°C (high grade)            132                     41.8                    72                                                  44.2   0.615
   Cough                                 291                     92.1                    159                                                 97.5   **0.018**
   Wheezing                              141                     44.6                    78                                                  47.9   0.501
   Rhinorrhea                            164                     51.9                    104                                                 63.8   **0.013**
   Apnea                                 38                      12.0                    23                                                  14.1   0.517
   Difficulty breathing                  264                     83.5                    152                                                 93.3   **0.003**
   Cyanosis                              86                      27.2                    51                                                  31.3   0.35
   Decreased appetite                    276                     87.3                    141                                                 86.5   0.796
   Hypoactivity                          257                     81.3                    143                                                 87.7   0.074
   Vomiting                              67                      21.3                    46                                                  28.2   0.090
   Diarrhea                              38                      12.0                    19                                                  11.7   0.906
   Altered mental status                 12                      3.8                     4                                                   2.5    0.438
  Presenting signs                                                                                                                                  
   Tachypnea                             242                     76.6                    137                                                 84.0   0.057
   Respiratory rate, mean (SD)           51.4 (11.2)                                     55.0 (10.5)                                                **0.001**
  SpO ~2~                                                                                                                                           0.061
   \> 94                                 278                     88.0                    131                                                 80.4   
   90--94                                9                       2.8                     12                                                  7.4    
   \< 90                                 22                      7.0                     17                                                  10.4   
  Retractions                            65                      20.6                    47                                                  28.8   **0.043**
  Flaring                                22                      7.0                     23                                                  14.1   **0.011**
  Grunting                               8                       2.5                     12                                                  7.4    **0.012**
  Wheezing                               85                      26.9                    65                                                  39.9   **0.004**
  Crackles                               198                     62.7                    107                                                 65.6   0.52
  Chest X-ray findings                                                                                                                              
   Interstitial markings                 95                      31.0                    64                                                  40.3   **0.047**
   Hyperinflation                        61                      19.9                    43                                                  27.0   0.081
   Atelectasis                           36                      11.8                    29                                                  18.2   0.056
   Peribronchial thickening              101                     33.0                    62                                                  39.0   0.199
   Consolidation                         63                      20.6                    27                                                  17.0   0.35
   Normal X-ray findings                 125                     40.8                    57                                                  35.8   0.295
   Leukocytosis                          83                      26.7                    43                                                  26.5   0.973
  Outcomes                                                                                                                                          
   ICU admission                         36                      11.4                    13                                                  8.0    0.242
   Death                                 3                       0.9                     0                                                   0.0    0.212
   Length of stay, mean (SD)             3.6 (2.5)                                       3.5 (2.2)                                                  0.635
  Severity                                                                                                                                          0.144
   Not severe                            216                     70.6                    103                                                 64.0   
   Severe                                90                      29.4                    58                                                  36.0   

Abbreviations: ICU, intensive care unit; RSV, respiratory syncytial virus; SD, standard deviation; SpO ~2~ , oxygen saturation.

Note: The demographic and clinical characteristics of RSV-positive patients were compared with those of RSV-negative patients using the chi-square test. A *p* -value of \< 0.05 was considered statistically significant.

Value in bold is statistically significant ( *p* -value \< 0.05).

Clinical Characteristics of HRV and HMPV
----------------------------------------

Comparison among RSV, HRV, and HMPV positive patients revealed high grade fever \> 38°C affecting RSV-positive children more than HRV-positive ( *p*  = 0.015). Leukocytosis was observed in RSV- and HRV-infected patients more than HMPV ( *p*  = 0.021). HMPV was positive in one of the death cases, neither RSV nor HRV were detected in any patients who died ( *p*  = 0.04). No differences were noted in other clinical symptoms or signs, LoS, and risk for ALRI among the three viruses.

Coinfection with RSV
--------------------

Coinfection with at least one virus was observed in 45 (27.6%) of the RSV-positive patients. Out of the 45 patients infected with RSV, 23 (14.1%) were coinfected with HRV, 10 (6.1%) with HMPV, 6 (3.7%) with HBoV, 3 (1.8%) with HAdV, 5 (3%) with HPIV (3 with HPIV1, 1 with HPIV3, and 1 with HPIV4), and 1 with HCoV2. The most frequent triple infection in RSV-positive patients was the coexistence of RSV, HRV, and HMPV (23, 14%). When patients coinfected with HRV or HMPV were compared with those infected with RSV alone with regard to the risks of increased LoS, the severity of ALRI, and ICU admission, the only significant finding was that RSV-positive patients had a higher risk of ICU admission than those infected with both RSV and HMPV ( *p*  = 0.008).

Clinical Characteristics of Children with Lower Respiratory Tract Infection (ALRI)
----------------------------------------------------------------------------------

In total, 463 (96.7%) of 479 children met the criteria for ALRI. Of the 479 patients, 161 (33.6%) had RSV-positive ALRI, 302 (63%) had RSV-negative ALRI, and 16 (3.3%) did not have ALRI. [Table 2](#TB1800105-2){ref-type="table"} shows the characteristics of patients with RSV-positive ALRI compared with those with RSV-negative ALRI. The two groups differ markedly in some presenting symptoms. RSV-positive ALRI were more likely to be younger, have chronic lung disease, and present with cough, rhinorrhea, difficulty breathing, grunting, wheezing, and a higher respiratory rate than RSV-negative ALRI.

###### Characteristics of patients with RSV-positive ALRI compared with those of patients with RSV-negative ALRI

  Variable                           RSV-negative ALRI   RSV-positive ALRI   *p* -Value [a](#FN1800105-6){ref-type="table-fn"}          
  ---------------------------------- ------------------- ------------------- --------------------------------------------------- ------ -----------
  Age (mo)                                                                                                                              **0.023**
   ≤6                                149                 49.3                90                                                  55.9   
   6.1--12                           56                  18.5                40                                                  24.8   
   12.1--24                          59                  19.5                21                                                  13     
   \>24                              38                  12.6                10                                                  6.2    
  Gender                                                                                                                                0.574
   Male                              190                 62.9                97                                                  60.2   
   Female                            112                 37.1                64                                                  39.8   
  Premature                          44                  14.6                25                                                  15.5   0.783
  Low birth weight                   69                  23.4                28                                                  17.6   0.152
  Chronic lung disease               9                   3                   12                                                  7.5    **0.028**
  Breastfeeding                      217                 71.9                122                                                 75.8   0.364
  Daycare                            21                  7                   13                                                  8.1    0.660
  Siblings under 5 y                 176                 58.3                86                                                  53.4   0.326
  Siblings 5 y or older              152                 50.3                83                                                  51.6   0.845
  Smoking exposure                   237                 78.5                116                                                 72     0.122
  Having chronic disease             48                  15.9                26                                                  16.1   0.943
  Family history of atopy            93                  30.8                58                                                  36     0.253
  Antibiotic prior hospitalization   159                 52.6                76                                                  47.2   0.264
  Presenting symptoms                                                                                                                   
   Fever \> 38°C (high grade)        120                 39.7                70                                                  43.5   0.436
   Cough                             285                 94.4                159                                                 98.8   **0.023**
   Wheezing                          141                 46.7                78                                                  48.4   0.718
   Rhinorrhea                        162                 53.6                103                                                 64.0   **0.032**
   Apnea                             23                  14.3                38                                                  12.6   0.606
   Difficulty breathing              264                 87.4                152                                                 94.4   **0.018**
   Cyanosis                          84                  27.8                51                                                  31.7   0.384
   Decreased appetite                263                 87.1                140                                                 87.0   0.968
   Hypoactivity                      243                 80.5                141                                                 87.6   0.053
   Vomiting                          64                  21.3                45                                                  28.0   0.107
   Diarrhea                          34                  11.3                19                                                  11.8   0.861
   Altered mental status             12                  4                   4                                                   2.5    0.403
  Presenting signs                                                                                                                      
   Tachypnea                         235                 77.8                137                                                 85.1   0.061
   Respiratory rate (SD)             51.6 (11.2)         55.3 (10.2)         **0.001**                                                  
  SpO ~2~                                                                                                                               0.081
   \>94                              264                 87.4                129                                                 80.1   
   90--94                            9                   3                   12                                                  7.5    
   \<90                              22                  7.3                 17                                                  10.6   
  Retractions                        65                  21.5                47                                                  29.2   0.066
  Flaring                            22                  7.3                 23                                                  14.3   **0.015**
  Grunting                           8                   2.6                 12                                                  7.5    **0.015**
  Wheezing                           85                  28.1                65                                                  40.4   **0.007**
  Crackles                           107                 66.5                130                                                 61.9   0.846
  X-ray findings                                                                                                                        
   Interstitial markings             95                  32.4                64                                                  40.8   0.078
   Hyperinflation                    61                  20.8                43                                                  27.4   0.115
   Atelectasis                       36                  12.3                29                                                  18.5   0.075
   Peribronchial thickening          101                 34.5                62                                                  39.5   0.291
   Consolidation                     63                  21.5                27                                                  17.2   0.277
   Normal X-ray findings             112                 38.2                55                                                  35     0.504
   Leukocytosis                      82                  27.6                42                                                  26.3   0.826
  Outcomes                                                                                                                              
   ICU admission                     36                  11.9                13                                                  8.1    0.200
   Death                             3                   1.0                 0                                                   0.0    0.205
   Length of stay, mean (SD)         3.6 (2.6)           3.5 (2.2)           0.589                                                      
  Severity                                                                                                                              0.171
   Not severe                        212                 70.2                103                                                 64.0   
   Severe                            90                  29.8                58                                                  36.0   

Abbreviations: ALRI, acute lower respiratory infection; ICU, intensive care unit; RSV, respiratory syncytial virus; SD, standard deviation; SpO ~2~ , oxygen saturation.

Note: The demographic and clinical characteristics of RSV-positive ALRI patients were compared with those of RSV-negative ALRI patients using the chi-square test. A *p* -value of \< 0.05 was considered statistically significant.

Value in bold is statistically significant ( *p* -value \< 0.05).

Factors Associated with Length of Stay
--------------------------------------

A history of prematurity, the presence of a chronic illness, SpO ~2~  \< 90%, and the presence of atelectasis and consolidation on chest X-rays were significantly associated with a longer mean LoS ( [Table 3](#TB1800105-3){ref-type="table"} ). Although patients infected with HMPV or HAdV had a longer mean of LoS than those of other patients, the differences were not significant ( *p * = 0.308). The analysis of RSV-positive ARI patients revealed that disease severity was the only significant predictive factor for increased LoS. The mean LoS was 4.5 days for RSV-positive patients with severe disease in comparison to 2.9 days for RSV-positive patients with nonsevere disease ( *p * \< 0.005).

###### Multivariate analysis of factors associated with length of stay in the whole cohort

                           Mean length of stay (95% confidence interval)   *p* -Value [a](#FN1800105-9){ref-type="table-fn"}
  ------------------------ ----------------------------------------------- ---------------------------------------------------
  Gestational age                                                          **0.003**
   Full-term               5.1 (4.5, 5.8)                                  
   Premature               6.2 (5.4, 7.0)                                  
  Chronic disease                                                          **0.015**
   No                      5.3 (4.6, 5.9)                                  
   Yes                     6.0 (5.3, 6.7                                   
  SpO ~2~                                                                  **0.000**
   \>94                    4.4 (3.9, 4.9)                                  
   90--94                  5.1 (4.0, 6.1)                                  
   \<90                    7.2 (6.4, 8.0)                                  
  Atelectasis                                                              **0.024**
   No                      5.3 (4.7, 5.9)                                  
   Yes                     6.0 (5.3, 6.7)                                  
  Consolidation                                                            **0.003**
   No                      5.2 (4.6, 5.8)                                  
   Yes                     6.1 (5.3, 6.8                                   
  Presence of viruses                                                      0.308
   No virus                5.4 (4.8, 6.0)                                  
   RSV                     5.3 (4.7, 6.0)                                  
   Rhinovirus              5.5 (4.7, 6.3)                                  
   Metapneumovirus         6.3 (5.2, 7.4)                                  
   Adenovirus              6.3 (4.8, 7.7)                                  
   RSV and another virus   5.1 (4.3, 5.9)                                  

Abbreviations: RSV, respiratory syncytial virus; SpO ~2~ , oxygen saturation.

Note: Multivariate analysis of factors associated with length of stay in the whole cohort was conducted using general linear model (GLM).

Value in bold is statistically significant ( *p* -value \< 0.05).

Factors Associated with Severe ALRI
-----------------------------------

[Table 4](#TB1800105-4){ref-type="table"} shows the multivariate analysis of the factors associated with severe ALRI. Patients with a history of prematurity had higher odds of severe ALRI (odds ratio \[OR\] = 2.6) compared with patients who were full-term. Patients admitted to KAUH (OR = 5.6) and those who did not attend daycare (OR = 2.8) were more likely than patients admitted to PRH and those who attended daycare, respectively, to have a severe form of the disease. The majority of children enrolled did not attend daycare (92.7%, *p*  = 0.000), and almost half of those (54.3%) were younger than 6 months. Compared with patients aged younger than 6 months, those aged 6.1 to 12 months were significantly less likely to have severe ALRI. HMPV-positive ALRI was significantly associated with an increased risk of severe disease. In RSV-positive patients, prematurity was the only significant predictive factor for severe ALRI (OR = 6.4; 95% confidence interval: 2.4, 17.6; *p * \< 0.005). Among children aged 6.1 to 12 months, compared with children who were not exclusively breastfed, those who had significantly had less severe disease ( *p*  = 0.046).

###### Multivariate analysis of factors associated with severe ALRI

                                              OR    95% confidence interval   *p* -Value [a](#FN1800105-12){ref-type="table-fn"}
  ------------------------------------------- ----- ------------------------- ----------------------------------------------------
  Gestational age (premature vs. full-term)   2.6   1.5, 4.7                  **0.001**
  Daycare (no vs. yes)                        2.8   7.3, 1.0                  **0.042**
  Hospital (KAUH vs. PRH)                     5.6   9.4, 3.3                  **0.000**
  Age (months)                                                                
    ≤  6                                      1.0                             
   6.1--12                                    0.4   0.2, 0.7                  **0.001**
   12.1--24                                   0.7   0.4, 1.3                  0.274
   \> 24                                      0.5   0.2, 1.0                  0.061
  Metapneumovirus-positive                    3.5   1.6, 7.6                  **0.002**

Abbreviations: ALRI, acute lower respiratory infection; KAUH, King Abdullah University Hospital; OR, odds ratio; PRH, Princess Rahmah Hospital.

Note: The risk factors of severe disease presentation were analyzed with binary logistic regression. The variables were included in the model stepwise, and those with *p * \< 0.10 in the univariate analysis were included in the multivariate risk factor model of risk factors. A *p* -value of \< 0.05 was considered statistically significant.

Value in bold is statistically significant ( *p* -value \< 0.05).

Discussion
==========

In this cohort in Northern Jordan during the winter of 2016, RSV was the most common viral cause of ARI/ALRI-associated hospitalization, following the global trend of RSV being the most common viral etiology of ARI in children less than 5 years old. [@JR1800105-2] [@JR1800105-3] [@BR1800105-8] [@JR1800105-9] [@JR1800105-10] Thus, RSV imposes a burden on the limited health care resources of Jordan. Furthermore, this finding was in line with the results observed in other countries in the Middle East, such as Qatar, Saudi Arabia, and Oman, which all identified RSV as the primary viral cause of ARI in children. [@JR1800105-23] [@JR1800105-24] [@JR1800105-25] The study period was during the peak of RSV infection based on what has been reported about the seasonality of RSV in temperate climates. [@JR1800105-7]

HRV was the second most commonly detected virus after RSV, which was similar to the results of the viral surveillance study in Amman conducted by Halasa et al. [@JR1800105-18] HRV was comparable to RSV with regard to the clinical presentation and disease severity. Therefore, HRV contributes to the burden of ARI in young children, which was also reported previously. [@JR1800105-26]

HMPV was the third most common virus causing ARI and was significantly associated with the severity of ALRI in the multivariate analysis. This finding is consistent with the results of the study conducted in Amman, in which HMPV was found to cause ALRI in 8.6% of the hospitalized children, with a peak of infection from February until April and was found to be an independent risk factor for severe disease presentation. [@JR1800105-27] HMPV is a known viral cause of ALRI in young children and has been previously associated with severe disease. Edwards et al [@JR1800105-28] demonstrated a significant association between HMPV infection in hospitalized children and increased supplemental oxygen use and ICU LoS.

Coinfection with other viruses was not uncommon. The presence of HRV or HMPV with RSV did not increase the LoS or the severity of the illness, which was consistent with the findings of other studies. [@JR1800105-29] [@JR1800105-30] In contrast, RSV infection alone was associated with an increased risk of ICU admission compared with children coinfected with RSV and HMPV. Compared with patients in older age classes, younger patients had an increased risk of RSV-associated hospitalization and increased severity of the disease. This finding is in agreement with the results of previous studies that reported that younger age is associated with a higher risk of severe RSV-associated disease and hospitalizations. [@JR1800105-3] [@BR1800105-8] [@JR1800105-31] [@JR1800105-32] [@JR1800105-33] Moreover, compared with RSV-negative children, RSV-positive children were more likely to have a higher respiratory rate, retraction, flaring, grunting, and wheezing, which are indicative of a more severe presentation.

Previous studies identified multiple risk factors for RSV-associated hospitalization and disease severity; these risk factors included being male, prematurity, having chronic lung disease, the lack of breast feeding, daycare attendance, living with other siblings, exposure to smoke, and having a chronic illness. [@JR1800105-3] [@JR1800105-11] [@JR1800105-31] [@JR1800105-33] [@JR1800105-34] [@JR1800105-35] [@JR1800105-36] [@JR1800105-37] [@JR1800105-38] [@JR1800105-39] [@JR1800105-40] [@JR1800105-41] [@JR1800105-42] [@JR1800105-43] [@JR1800105-44] [@JR1800105-45] This study found no difference in the risk of RSV hospitalization according to gender as reported previously. [@JR1800105-3] [@JR1800105-31] Prematurity did not increase the risk of RSV infection, which may be explained by the fact that all premature infants in this study were late-preterm (\>29--36 weeks). It has been reported that late-preterm infants have a lower risk of RSV acquisition than early-preterm infants. [@JR1800105-3] [@JR1800105-31] [@JR1800105-45] Prematurity, however, increased the severity of both RSV-positive and RSV-negative ALRI, as well as the LoS in the entire cohort. Chronic lung disease increased the risk of RSV infection and RSV-associated ALRI; however, it was not a risk factor for increased severity in our study. When exclusively breastfed children were compared with the nonexclusively breastfed children, the former had significantly less severe ALRI which is consistent with the previously reported protection of breast feeding being related to exclusiveness. [@JR1800105-46] Nishimura et al also demonstrated a difference in the LoS and oxygen use according to breast feeding being partial or full. [@JR1800105-47] The lack of daycare attendance was a risk factor for increased severity, which could be attributed to the majority of children (92.7%) not attending daycare in this cohort. This was also confounded by the fact that of those who did not attend daycare, almost half were below the age of 6 months, which is the age group with more severe disease than was found in older patients. Patients admitted to KAUH rather than PRH had more severe disease presentation, which can be attributed to KAUH being a referral hospital, making this observation expected.

Notably, chest imaging was ordered in almost all admitted cases (97%) reflecting a lack of adherence to the international guidelines regarding chest radiography indications in young children with ALRI. [@JR1800105-40] [@JR1800105-42] The presence of atelectasis and consolidation were significantly related to increased LoS. In an outpatient study performed by Shaw et al, atelectasis was also associated with the severity of ALRI. [@JR1800105-48] Consolidation can also be attributed to secondary bacterial infection which was not tested in this study population.

There are multiple limitations of this study. First, the presence of bacteria was not tested, and secondary bacterial infection could influence the clinical presentation and outcome. Second, the surveillance was limited to the winter season, potentially underestimating the burden of the disease and the seasonality of RSV infection. Third, there was a lack of testing for influenza A and B viruses which have implications in patients hospitalized with ALRI in Jordan as has been extensively studied previously. [@JR1800105-49]

Conclusion
==========

This study is the first prospective surveillance study showing the significant burden of ARI/ALRI-associated hospitalization caused by viruses during the winter season in Irbid, Northern Jordan, using a sensitive detection to estimate the burden of the illness in the nation of Jordan and contribution to the epidemiological data regarding viral ARI in young children in the Middle East. RSV was identified as the most common viral cause of ARI. Other viruses, such as HMPV, should be considered as the etiology for severe ALRI. Risk factors for increased LoS and severe disease presentation of ALRI were determined in the population of Northern Jordan. Exclusive breast feeding was essential in decreasing the severity of ALRI. These findings are crucial for stakeholders in the health care system, to prioritize health care interventions, particularly in settings with limited resources. Laboratory confirmation of viral etiology would help minimize antibiotic use in managing ARI. This study may also aid measures to implement future strategies for RSV vaccination when available.

**Conflict of Interest** None declared.

This study was approved by the Institutional Review Board of Jordan University of Science and Technology, reference number: 28/91/2015.
